A fluorescent derivative of methotrexate as an intracellular marker for dihydrofolate reductase in L1210 cells

Abstract

Fluorescein isothiocyanate coupled via a diaminopentyl-linking group to methotrexate ( G.R. Gapski, J. M. Whiteley, J. I. Rader, P. L. Cramer, G. B. Henderson, V. Neef, and F. M. Huennekens, 1975, J. Med. Chem. 18, 526–528) produces a fluorescent compound which is a strong inhibitor of dihydrofolate reductase ( K i = 60 nM) purified from L1210 murine leukemia cells. The fluorescent methotrexate derivative is preferentially taken up by methotrexate-resistant rather than wild-type L1210 cells grown in culture and acts as a visual marker for dihydrofolate reductase ( K D = 50 nM) during both purification and polyacrylamide electrophoresis. Uptake, which is proportional to the level of dihydrofolate reductase (often an indicator of the degree of acquired cellular methotrexate resistance), occurs slowly and via a route that is distinct from the carrier-mediated system utilized by these cells to transport methotrexate.